DMAB

AcronymDefinition
DMABDesignated Male at Birth
DMABp-dimethylaminobenzaldehyde (lab analysis chemical)
DMABDirect Mail Advisory Board (est. 1995; UN Universal Postal Union)
DMABDu Monde au Balcon (French: Balcony of the World)
DMABDu Monde Aux Balkans (Grenoble, France festival)
References in periodicals archive ?
Inovio's important partner-funded programs are unaffected by the realignment including: MEDI0457 in HPV-related cancers with AstraZeneca; our Lassa and MERS vaccine programs with CEPI; the Bill & Melinda Gates Foundation-funded Zika dMAb clinical development program; and Inovio's commercial intra-dermal 3PSP delivery device development funded by Medical CBRN Defense Consortium (MCDC).
This research publication is significant because it is the first to report on the use of Inovio dMAb technology to develop novel monoclonal antibody-based therapies targeting checkpoint inhibitors.
The title compound, p-(dimethylamino)azobenzene (DMAB), was purchased from SigmaAldrich, having greater than 99% purity and no additional purification was made.
After 2 years, TPTD alone was associated with a 2.7% increase in TBS over baseline (P = .009), while DMAB alone was associated with a 1.8% increase (P = .118 vs.
During the adaptation of detection conditions, two derivatisation agents used commonly in the detection of ionophores were compared: vanillin and DMAB. As expected from bibliographical data [10], DMAB-derivatives gave higher signals.
p-dimethyl amino benzaldehyde (DMAB) and N-acetylglucosamine, (GlcNac) was purchased from Sigma (St Louis, MO, USA).
The UPU meets annually at the DMAB Summit, a platform created to discuss industry developments and trends to tackle key issues.
8) consisting of camphorquinone (CQ) and N,N-dimethylaminobenzoic acid ethyl ester (DMAB) was selected for the preparation of test specimens of the monomers because of its known biocompatibility.
(nBuCp)[.sub.2]Zr[Cl.sub.2] catalyst (Eurocene 5031, Crompton), N,N'-dimethylanilinium tetra-kis(pentafluorophenyl)borate (DMAB, Albemarle), dimethyldichlorosilane (+99.5%, Fluka), t-butylamine (for synthesis, Merck), n-butyllithium (solution 15% in hexane, Merck), 1,2,3,4-tetramethyl-1,3-cyclopentadiene (85%, Aldrich), triisobutyl aluminum (TIBAL, Crompton), trihexyl aluminum (THA, Crompton), and butyloctyl magnesium (BOMAG, Crompton) were used without further purification.
(2005) reported the first study of the clinical toxicity of dimethylamine borane (DMAB) poisoning, particularly the neurologic manifestations in the central nervous system and peripheral nervous system.
To 100 [micro]L of sample or standard was added 1.7 mL of a solution containing 3.2 mM 3-(dimethylamino) benzoic acid (DMAB) and 0.22 mM 3-methyl-2-benzothiazolinone (MBTH) in 50 mM citrate buffer, pH 3.8.